Ferguson James J. III 4
4 · Matinas BioPharma Holdings, Inc. · Filed Jun 19, 2020
Insider Transaction Report
Form 4
Ferguson James J. III
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2020-06-17+250,000→ 250,000 totalExercise: $0.81Exp: 2030-06-16→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. Vesting is performance based and tied to achievement of positive topline ENHANCE-IT data (the "Milestone"). The option vests as to 1/3 upon achievement of the Milestone, with the remaining options to vest 1/3 on the first anniversary of such Milestone and 1/3 on the second anniversary of such Milestone.